Effect of Carbon Monoxide-Releasing Molecules II-liberated CO on Suppressing Inflammatory Response in Sepsis by Interfering with Nuclear Factor Kappa B Activation

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Qin, Weiting ^a   Zhang, Jinli ^a   Lv, Wanghui ^a   Wang, Xu ^a   Sun, Bingwei ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBON MONOXIDE; GRANULOCYTE ANTIBODY; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; NUCLEAR PROTEIN; POLYACRYLAMIDE GEL; POLYCLONAL ANTIBODY; POLYMORPHONUCLEAR LEUKOCYTES; TRICARBONYLDICHLORORUTHENIUM DIMER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; INFLAMMATION; LIVER; LUNG; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLYMORPHONUCLEAR CELL; PROTEIN SYNTHESIS INHIBITION; SEPSIS; SURVIVAL RATE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CARBON MONOXIDE; CELL ADHESION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIVER; LUNG; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE; ORGANOMETALLIC COMPOUNDS; REACTIVE OXYGEN SPECIES; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885055767     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075840     Document Type: Article

References (54)

1. Tse MT, (2013) Trial watch: Sepsis study failure highlights need for trial design rethink. Nat Rev Drug Discov 12: 334.
2. Sriskandan S, (2011) Severe peripartum sepsis. J R Coll Physicians Edinb 41: 339-346.
3. Remick DG, (2007) Pathophysiology of sepsis. Am J Pathol 170: 1435-1444.
4. Cakir B, Cevik H, Contuk G, Ercan F, Eksioglu-Demiralp E, et al. (2005) Leptin ameliorates burn-induced multiple organ damage and modulates postburn immune response in rats. Regul Pept 125: 135-144.
5. Chen LW, Chang WJ, Wang JS, Hsu CM, (2006) Thermal injury-induced peroxynitrite production and pulmonary inducible nitric oxide synthase expression depend on JNK/AP-1 signaling. Crit Care Med 34: 142-150.
6. Sagara D, Unno N, Yamamoto N, Suzuki M, Nishiyama M, et al. (2010) Trans-Serosal Leakage of Proinflammatory Mediators during Abdominal Aortic Aneurysm Repair: Role of Phospholipase A2 in Activating Leukocytes. Ann Vasc Dis 3: 131-139.
7. Rupesh KR, Priya AM, Sundarakrishnan B, Venkatesan R, Lakshmi BS, et al. (2010) 2,2′-bipyridyl based copper complexes down regulate expression of pro-inflammatory cytokines and suppress MAPKs in mitogen induced Peripheral blood mononuclear cells. Eur J Med Chem 45: 2141-2146.
8. Hansbrough JF, Wikstrom T, Braide M, Tenenhaus M, Rennekampff OH, et al. (1996) Neutrophil activation and tissue neutrophil sequestration in a rat model of thermal injury. J Surg Res 61: 17-22.
9. Piantadosi CA, (2002) Biological chemistry of carbon monoxide. Antioxid Redox Signal 4: 259-270.
10. Coburn RF, (2012) The measurement of endogenous carbon monoxide production. J Appl Physiol 112: 1949-1955.
11. Ozaki KS, Yoshida J, Ueki S, Pettigrew GL, Ghonem N, et al. (2012) Carbon monoxide inhibits apoptosis during cold storage and protects kidney grafts donated after cardiac death. Transpl Int 25: 107-117.
12. Ryter SW, Choi AM, (2013) Carbon monoxide: present and future indications for a medical gas. Korean J Intern Med 28: 123-140.
13. Schwer CI, Stoll P, Rospert S, Fitzke E, Schallner N, et al. (2013) Carbon monoxide releasing molecule-2 CORM-2 represses global protein synthesis by inhibition of eukaryotic elongation factor eEF2. Int J Biochem Cell Biol 45: 201-212.
14. Basuroy S, Tcheranova D, Bhattacharya S, Leffler CW, Parfenova H, (2011) Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-alpha-induced apoptosis. Am J Physiol Cell Physiol 300: C256-265.
15. Otterbein LE, Soares MP, Yamashita K, Bach FH, (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455.
16. Otterbein LE, Mantell LL, Choi AM, (1999) Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 276: L688-694.
17. Otterbein LE, Otterbein SL, Ifedigbo E, Liu F, Morse DE, et al. (2003) MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Am J Pathol 163: 2555-2563.
18. Chapman JT, Otterbein LE, Elias JA, Choi AM, (2001) Carbon monoxide attenuates aeroallergen-induced inflammation in mice. Am J Physiol Lung Cell Mol Physiol 281: L209-216.
19. Motterlini R, Mann BE, Johnson TR, Clark JE, Foresti R, et al. (2003) Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 9: 2525-2539.
20. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, et al. (2002) Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90: E17-24.
21. Motterlini R, Sawle P, Hammad J, Bains S, Alberto R, et al. (2005) CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 19: 284-286.
22. Johnson TR, Mann BE, Clark JE, Foresti R, Green CJ, et al. (2003) Metal carbonyls: a new class of pharmaceuticals? Angew Chem Int Ed Engl 42: 3722-3729.
23. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, et al. (2004) Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 142: 453-460.
24. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, et al. (2003) Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93: e2-8.
25. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, et al. (2004) Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286: H1649-1653.
26. Liu DM, Sun BW, Sun ZW, Jin Q, Sun Y, et al. (2008) Suppression of inflammatory cytokine production and oxidative stress by CO-releasing molecules-liberated CO in the small intestine of thermally-injured mice. Acta Pharmacol Sin 29: 838-846.
27. Sun B, Sun Z, Jin Q, Chen X, (2008) CO-releasing molecules (CORM-2)-liberated CO attenuates leukocytes infiltration in the renal tissue of thermally injured mice. Int J Biol Sci 4: 176-183.
28. Sun B-W, Chen Z-Y, Chen X, Liu C, (2007) Attenuation of Leukocytes Sequestration by Carbon Monoxide-Releasing Molecules: Liberated Carbon Monoxide in the Liver of Thermally Injured Mice. Journal of Burn Care & Research 28: 173-181.
29. Sun B, Sun H, Liu C, Shen J, Chen Z, et al. (2007) Role of CO-Releasing Molecules Liberated CO in Attenuating Leukocytes Sequestration and Inflammatory Responses in the Lung of Thermally Injured Mice. Journal of Surgical Research 139: 128-135.
30. Wang X, Cao J, Sun BW, Liu DD, Liang F, et al. (2012) Exogenous carbon monoxide attenuates inflammatory responses in the small intestine of septic mice. World J Gastroenterol 18: 5719-5728.
31. Karahocagil MK, Aslan M, Ceylan MR, Cikman A, Sunnetcioglu M, et al. (2012) Serum myeloperoxidase activity and oxidative stress in patients with acute brucellosis. Clin Biochem 45: 733-736.
32. Khalatbary AR, Ahmadvand H, (2011) Effect of oleuropein on tissue myeloperoxidase activity in experimental spinal cord trauma. Iran Biomed J 15: 164-167.
33. Lomas JL, Chung CS, Grutkoski PS, LeBlanc BW, Lavigne L, et al. (2003) Differential effects of macrophage inflammatory chemokine-2 and keratinocyte-derived chemokine on hemorrhage-induced neutrophil priming for lung inflammation: assessment by adoptive cells transfer in mice. Shock 19: 358-365.
34. Sun B, Zou X, Chen Y, Zhang P, Shi G, (2008) Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVEC. Int J Biol Sci 4: 270-278.
35. Cepinskas G, Lush CW, Kvietys PR, (1999) Anoxia/reoxygenation-induced tolerance with respect to polymorphonuclear leukocyte adhesion to cultured endothelial cells. A nuclear factor-kappaB-mediated phenomenon. Circ Res 84: 103-112.
36. Parsa CJ, Matsumoto A, Kim J, Riel RU, Pascal LS, et al. (2003) A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112: 999-1007.
37. Sanadgol N, Mostafaie A, Bahrami G, Mansouri K, Ghanbari F, et al. (2010) Elaidic acid sustains LPS and TNF-alpha induced ICAM-1 and VCAM-I expression on human bone marrow endothelial cells (HBMEC). Clin Biochem 43: 968-972.
38. Panes J, Perry MA, Anderson DC, Manning A, Leone B, et al. (1995) Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol 269: H1955-1964.
39. Harjai M, Bogra J, Kohli M, Pant AB, (2013) Is suppression of apoptosis a new therapeutic target in sepsis? Anaesth Intensive Care 41: 175-183.
40. Condotta SA, Cabrera-Perez J, Badovinac VP, Griffith TS, (2013) T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression. Crit Rev Immunol 33: 23-40.
41. Hernandez G, Bruhn A, Ince C, (2013) Microcirculation in sepsis: new perspectives. Curr Vasc Pharmacol 11: 161-169.
42. Riedemann NC, Guo RF, Ward PA, (2003) The enigma of sepsis. J Clin Invest 112: 460-467.
43. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, et al. (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428.
44. Nakao A, Moore BA, Murase N, Liu F, Zuckerbraun BS, et al. (2003) Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut 52: 1278-1285.
45. Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, et al. (2005) Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 145: 800-810.
46. Odobasic D, Kitching AR, Yang Y, O'Sullivan KM, Muljadi RC, et al. (2013) Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function. Blood 121: 4195-4204.
47. Zhang N, Francis KP, Prakash A, Ansaldi D, (2013) Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles. Nat Med 19: 500-505.
48. Park KH, Lee TH, Kim CW, Kim J, (2013) Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs. J Immunol 190: 6550-6558.
49. Wantha S, Alard JE, Megens RT, van der Does AM, Doring Y, et al. (2013) Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res 112: 792-801.
50. Deveci M, Eski M, Sengezer M, Kisa U, (2000) Effects of cerium nitrate bathing and prompt burn wound excision on IL-6 and TNF-alpha levels in burned rats. Burns 26: 41-45.
51. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV (2003) Modulation of endotoxin-induced endothelial activity by microtubule depolymerization. J Trauma 54: 104-112; discussion 112-103.
52. Schmidt A, Oberle N, Weiss EM, Vobis D, Frischbutter S, et al. (2011) Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-kappaB, and NFAT signaling in conventional T cells. Sci Signal 4: ra90.
53. Madonna R, De Caterina R, (2012) Relevance of new drug discovery to reduce NF-kappaB activation in cardiovascular disease. Vascul Pharmacol 57: 41-47.
54. Han EH, Yang JH, Kim HK, Choi JH, Khanal T, et al. (2012) 1-Bromopropane up-regulates cyclooxygenase-2 expression via NF-kappaB and C/EBP activation in murine macrophages. Food Chem Toxicol 50: 1616-1622.